Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Exubera vs Subcutaneous Insulin in Diabetics with COPD
NCT00138671Phase 3Terminated
- Sponsor
- Pfizer
- Start
- Jan 2003
- Primary completion
- Sep 2008
- Modality
- Biologic
- Countries
- 5
01
Overview
A Phase 3 trial of insulin human in type 1 diabetes mellitus (T1D), type 2 diabetes mellitus (T2DM), sponsored by Pfizer. Started Jan 2003; status: terminated.
02
Drugs
insulin human
03
Conditions
type 1 diabetes mellitus (T1D)type 2 diabetes mellitus (T2DM)
Beyond the preview
Go deeper on NCT00138671.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00138671.